background image

Paid Clinical Trials Murfreesboro

Discover 1,214 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

for
Atoptic Dermatitis
1 location in Murfreesboro
Sponsor: Evommune, Inc.

Sex: All

Age: 18+

Code: NCT07150845

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
1 location in Smyrna
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
1 location in Hermitage
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
1 location in Hermitage
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
1 location in Franklin
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
1 location in Nashville
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Active & Responsive

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

for
Migraine
1 location in Franklin
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06417775

Phase3, Recruiting
Active & Responsive

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

for
Progressive Pulmonary Fibrosis
1 location in Franklin
Sponsor: Avalyn Pharma Inc.

Sex: All

Age: 18+

Code: NCT06329401

Phase2, Recruiting
Active & Responsive

A Study of RSLV-132 in Females With Sjögren's Disease

for
Primary Sjögren Syndrome
1 location in Nashville
Sponsor: Resolve Therapeutics

Sex: Female

Age: 18 - 70+

Code: NCT06440525

Phase2, Recruiting
Active & Responsive

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for
Treatment Resistant Depression
1 location in Brentwood
Sponsor: LivaNova

Sex: All

Age: 18+

Code: NCT03887715

Recruiting